Population Health Management Market

研究執行與發布：MarketsandMarkets　·　發布日期 2026-07-24　·　335 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

完整報告名稱與涵蓋範圍

Population Health Management Market by Component (Software, Services), Functionality (Analytics, Care Management, Risk & Predictive Analytics, VBC), End User (Hospital, Clinic, Payer, Public Health, Employer), Organization Size - Global Forecast to 2031

報告摘要

The population health management market is projected to reach USD 98.41 billion by 2031 from USD 46.93 billion in 2026, at a CAGR of 16.0%. Market growth is primarily driven by the increasing shift toward value-based care, the rising prevalence of chronic diseases, and the growing need to improve patient outcomes while reducing healthcare costs. Healthcare providers, payers, government agencies, and employers are increasingly adopting population health management solutions to identify high-risk populations, enhance care coordination, manage chronic conditions, and support preventive care initiatives. The integration of clinical, claims, pharmacy, laboratory, and social determinants of health (SDOH) data enables organizations to generate actionable insights, improve risk stratification, and deliver personalized care. Additionally, the growing adoption of cloud-based platforms, artificial intelligence (AI), predictive analytics, remote patient monitoring, and interoperable healthcare systems is strengthening population health management capabilities. As healthcare organizations continue to prioritize data-driven decision-making, care coordination, and value-based reimbursement models, demand for comprehensive PHM solutions is expected to accelerate throughout the forecast period. “The software segment accounted for a larger share of the population health management market in 2025.” Based on component, the population health management market has been segmented into software and services. The software segment accounted for a larger market share in 2025, driven by the widespread adoption of population health platforms for risk stratification, care management, predictive analytics, patient engagement, and clinical decision support. Healthcare providers and payers are increasingly investing in software solutions to integrate clinical, claims, pharmacy, and social determinants of health (SDOH) data, enabling real-time population insights and improved care coordination. The growing transition toward value-based care, increasing adoption of cloud-based PHM platforms, and rising demand for AI-enabled analytics and interoperability have further strengthened the dominance of the software segment in the population health management market. “The cloud-based segment is expected to exhibit the fastest growth during the forecast period.” Based on delivery mode, the population health management market has been segmented into cloud-based, on-premises, and hybrid models. Of these, the cloud-based segment is expected to record the fastest growth during the forecast period. This fast-paced growth is mainly driven by the increasing demand for scalable, cost-effective, and interoperable healthcare solutions that support value-based care initiatives. Cloud-based PHM platforms enable seamless integration of clinical, claims, pharmacy, laboratory, and social determinants of health (SDOH) data while providing real-time analytics, remote patient monitoring, and AI-driven insights. Their lower upfront costs, faster deployment, automatic software updates, and ability to securely share data across multiple care settings are encouraging widespread adoption among healthcare providers, payers, and public health organizations, making cloud-based deployment the fastest-growing segment in the population health management market. “Asia Pacific is expected to register the highest growth rate during the forecast period.” Asia Pacific is expected to witness the highest CAGR in the population health management market during the forecast period. This high growth rate is mainly supported by the rapid digitalization of healthcare systems, increasing government initiatives promoting healthcare IT adoption, rising prevalence of chronic diseases, and expanding investments in healthcare infrastructure across countries such as China, India, Japan, Australia, and South Korea. The growing adoption of electronic health records (EHRs), cloud-based healthcare platforms, AI-powered analytics, and remote patient monitoring solutions is enabling healthcare organizations to improve care coordination and population health outcomes. Furthermore, increasing awareness of preventive healthcare, expanding health insurance coverage, and the transition toward value-based care are accelerating the adoption of population health management solutions across the region, making Asia Pacific the fastest-growing regional market during the forecast period. The breakdown of primary participants is as given below: • By Company Type - Tier 1: 37%, Tier 2: 22%, and Tier 3: 41% • By Designation - C-level: 55%, Director-level: 20%, and Others: 25% • By Region - North America: 30%, Europe: 45%, Asia Pacific: 20%, Latin America: 3%, Middle East & Africa: 2% Oracle (US), Veradigm LLC (US), Merative (US), Epic Systems Corporation (US), Koninklijke Philips N.V. (Netherlands), Health Catalyst (US), and Optum Inc. (US) are some of the key players in the population health management market. The study includes an in-depth competitive analysis of these key market players, with their company profiles, recent developments, and key market strategies. Research Coverage This research report categorizes the population health management market by component (Software, Services), functionality (Population Health Analytics, Care Management & Care Coordination, Risk Stratification & Predictive Analytics, Patient Engagement, Physician Engagement, Quality & Value-based Care Management, Interoperability & Data Integration, Others), delivery mode (Cloud-based, On-premises, Hybrid), organization size (Large Enterprises, Medium Enterprises, Small Enterprises), end user (Healthcare Providers [Hospitals & Health Systems, Physician Practices & Clinics, Other Healthcare Providers], Healthcare Payers [Private Payers, Public Payers], Government & Public Health Agencies, Employers, Life Sciences), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the population health management market. A detailed analysis of the key industry players has been done to provide insights into their business overview, software, and services; key strategies; and contracts, partnerships, agreements, new product & service launches, mergers & acquisitions, and recent developments associated with the population health management market. Competitive analysis of upcoming and established players in the population health management market ecosystem is covered in this report. Reasons to Buy this Report The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the population health management market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities. The report provides insights on the following pointers: • The report provides insights on the following pointers: Analysis of key drivers (Expansion of Value-based Care (VBC) and Risk-based Reimbursement Models, Growing Focus on Reducing Hospital Readmissions through Coordinated Care, Growing Adoption of Al-Driven Predictive Analytics within Healthcare Organizations, Increasing Availability of Interoperable Digital Health Data), restraints (Persistent Healthcare Data Interoperability Challenges, Rising Data Breach Concerns), opportunities (Integration of Social Determinants of Health (SDOH) into Population Health Strategies, Expansion of Remote Patient Monitoring and Virtual Care Programs, Growing Demand for Al-powered Care Management Automation), and challenges (Demonstrating Measurable Return on Investment (ROI), Clinical Workflow Integration and User Adoption) influencing the growth of the population health management market. • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the population health management market • Market Development: Comprehensive information about lucrative markets; the report analyses the population health management market across varied regions. • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the population health management market • Competitive Assessment: In-depth assessment of market shares, growth strategies, and software offerings of leading players like Oracle (US), Veradigm LLC (US), Merative (US), Epic Systems Corporation (US), Koninklijke Philips N.V. (Netherlands), i2i Population Health (US), Health Catalyst (US), and Optum Inc. (US), among others, in the population health management market.

授權報價

Single User Licence	$4,950 USD
Multi User Licence	$6,650 USD
Corporate User Licence	$8,150 USD
Global User Licence	$10,000 USD

目錄 Table of Contents

1 INTRODUCTION 31 1.1 STUDY OBJECTIVES 31 1.2 MARKET DEFINITION 31 1.3 MARKET SCOPE 32 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 32 1.3.2 INCLUSIONS & EXCLUSIONS 33 1.3.3 YEARS CONSIDERED 34 1.4 CURRENCY CONSIDERED 34 1.5 LIMITATIONS 35 1.6 STAKEHOLDERS 35 1.7 SUMMARY OF CHANGES 36 2 EXECUTIVE SUMMARY 37 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 37 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 39 2.3 DISRUPTIVE TRENDS SHAPING THE MARKET 40 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 41 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 42 3 PREMIUM INSIGHTS 43 3.1 POPULATION HEALTH MANAGEMENT MARKET OVERVIEW 43 3.2 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT AND REGION 44 3.3 POPULATION HEALTH MANAGEMENT MARKET: GEOGRAPHIC SNAPSHOT 44 4 MARKET OVERVIEW 45 4.1 INTRODUCTION 45 4.2 MARKET DYNAMICS 45 4.2.1 DRIVERS 46 4.2.1.1 Expansion of value-based care (VBC) and risk-based reimbursement models 46 4.2.1.2 Growing focus on reducing hospital readmissions through coordinated care 46 4.2.1.3 Growing adoption of Al-driven predictive analytics within healthcare organizations 47 4.2.1.4 Increasing availability of interoperable digital health data 47 4.2.2 RESTRAINTS 48 4.2.2.1 Persistent healthcare data interoperability challenges 48 4.2.2.2 Rising data breach concerns 48 4.2.3 OPPORTUNITIES 50 4.2.3.1 Integration of Social Determinants of Health (SDOH) into population health strategies 50 4.2.3.2 Expansion of remote patient monitoring and virtual care programs 51 4.2.3.3 Growing demand for AI-powered care management automation 51 4.2.4 CHALLENGES 52 4.2.4.1 Demonstrating measurable return on investment 52 4.2.4.2 Clinical workflow integration and user adoption 52 4.3 UNMET NEEDS AND WHITE SPACES 53 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 53 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 54 5 INDUSTRY TRENDS 56 5.1 PORTER’S FIVE FORCES ANALYSIS 56 5.1.1 BARGAINING POWER OF SUPPLIERS 57 5.1.2 BARGAINING POWER OF BUYERS 57 5.1.3 THREAT OF SUBSTITUTES 57 5.1.4 THREAT OF NEW ENTRANTS 57 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 58 5.2 MACROECONOMIC INDICATORS 58 5.2.1 INTRODUCTION 58 5.2.2 GDP TRENDS AND FORECAST 58 5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY 58 5.3 VALUE CHAIN ANALYSIS 59 5.3.1 RESEARCH & PRODUCT DEVELOPMENT 60 5.3.2 TECHNOLOGY INPUTS & INFRASTRUCTURE 60 5.3.3 PLATFORM DEVELOPMENT & INTEGRATION 60 5.3.4 DISTRIBUTION 61 5.3.5 MARKETING & SALES 61 5.3.6 POST-SALES SERVICES 61 5.4 ECOSYSTEM ANALYSIS 61 5.5 PRICING ANALYSIS 63 5.5.1 INDICATIVE PRICE FOR POPULATION HEALTH MANAGEMENT SOLUTIONS, BY COMPONENT (2025) 63 5.5.2 INDICATIVE PRICE FOR POPULATION HEALTH MANAGEMENT SOLUTIONS, BY REGION (2025) 64 5.6 KEY CONFERENCES AND EVENTS, 2026–2027 65 5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 66 5.8 INVESTMENT AND FUNDING SCENARIO 67 5.9 CASE STUDY ANALYSIS 68 5.10 IMPACT OF 2025 US TARIFF – POPULATION HEALTH MANAGEMENT MARKET 69 5.10.1 INTRODUCTION 69 5.10.2 KEY TARIFF RATES 70 5.10.3 PRICE IMPACT ANALYSIS 71 5.10.4 IMPACT ON COUNTRY/REGION 71 5.10.4.1 US 71 5.10.4.2 Europe 71 5.10.4.3 Asia Pacific 72 5.10.5 IMPACT ON END USERS 72 5.10.5.1 Healthcare providers 72 5.10.5.2 Healthcare payers 72 5.10.5.3 Government & public health agencies 72 5.10.5.4 Employers 72 5.10.5.5 Life sciences 73 6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION 74 6.1 KEY EMERGING TECHNOLOGIES 74 6.1.1 AI-POWERED PREDICTIVE ANALYTICS & RISK STRATIFICATION 74 6.1.2 GENERATIVE AI & CLINICAL DECISION SUPPORT 74 6.1.3 DIGITAL CARE MANAGEMENT & REMOTE PATIENT MONITORING (RPM) 74 6.2 COMPLEMENTARY TECHNOLOGIES 75 6.2.1 EHR, EMR, AND CLINICAL WORKFLOW INTEGRATION 75 6.2.2 HEALTHCARE DATA PLATFORMS & INTEROPERABILITY (FHIR, HL7, APIS) 75 6.3 ADJACENT TECHNOLOGIES 75 6.3.1 VALUE-BASED CARE & CARE COORDINATION PLATFORMS 75 6.3.2 SOCIAL DETERMINANTS OF HEALTH (SDOH) & COMMUNITY HEALTH PLATFORMS 76 6.4 TECHNOLOGY/PRODUCT ROADMAP 76 6.5 PATENT ANALYSIS 77 6.5.1 PATENT PUBLICATION TRENDS FOR POPULATION HEALTH MANAGEMENT MARKET 77 6.5.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 78 6.6 FUTURE APPLICATIONS 80 6.6.1 PRECISION POPULATION HEALTH & AI-DRIVEN RISK PREDICTION 80 6.6.2 CONTINUOUS CARE ECOSYSTEMS THROUGH REMOTE MONITORING & DIGITAL THERAPEUTICS 81 6.6.3 SOCIAL DETERMINANTS OF HEALTH (SDOH) INTELLIGENCE & COMMUNITY-BASED CARE ORCHESTRATION 81 6.7 IMPACT OF AI/GEN AI ON POPULATION HEALTH MANAGEMENT MARKET 81 6.7.1 INTRODUCTION 81 6.7.2 MARKET POTENTIAL OF AI/GEN AI IN POPULATION HEALTH MANAGEMENT 82 6.7.3 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION 83 6.7.3.1 AI-powered claims management and revenue cycle optimization at Sentara Health 83 6.7.4 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 84 6.7.4.1 Healthcare analytics market 84 6.7.4.2 Healthcare interoperability market 84 6.7.4.3 Remote patient monitoring market 85 6.7.5 USER READINESS AND IMPACT ASSESSMENT 85 6.7.5.1 User readiness 85 6.7.5.1.1 Healthcare providers 85 6.7.5.1.2 Healthcare payers 85 6.7.5.2 Impact assessment 85 6.7.5.2.1 User A: Healthcare providers 85 6.7.5.2.2 User B: Healthcare payers 86 7 REGULATORY LANDSCAPE 87 7.1 REGIONAL REGULATIONS AND COMPLIANCE 87 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88 7.1.2 REGULATORY FRAMEWORK 91 7.1.2.1 North America 91 7.1.2.2 Europe 92 7.1.2.3 Asia Pacific 93 7.1.2.4 Latin America 94 7.1.2.5 Middle East & Africa 94 7.1.3 INDUSTRY STANDARDS 95 8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 96 8.1 INTRODUCTION 96 8.2 DECISION-MAKING PROCESS 96 8.3 KEY STAKEHOLDERS AND BUYING EVALUATION CRITERIA 97 8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 97 8.3.2 BUYING CRITERIA 98 8.4 ADOPTION BARRIERS & INTERNAL CHALLENGES 99 8.5 UNMET NEEDS FROM VARIOUS END USERS 99 8.5.1 UNMET NEEDS 100 8.5.2 END-USER EXPECTATIONS 101 8.6 MARKET PROFITABILITY 101 9 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT 102 9.1 INTRODUCTION 103 9.2 SOFTWARE 103 9.2.1 AI-POWERED ANALYTICS PLATFORMS PROPEL PHM SOFTWARE ADOPTION ACROSS VALUE-BASED ECOSYSTEMS 103 9.3 SERVICES 104 9.3.1 MANAGED CARE COORDINATION SERVICES BRIDGE TECHNOLOGY GAPS ACROSS FRAGMENTED HEALTH SYSTEMS 104 10 POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY 106 10.1 INTRODUCTION 107 10.2 POPULATION HEALTH ANALYTICS 107 10.2.1 REAL-WORLD DATA INTEGRATION FUELS ACTIONABLE ANALYTICS ACROSS ENTIRE PATIENT POPULATIONS 107 10.3 CARE MANAGEMENT & CARE COORDINATION 108 10.3.1 ACO EXPANSION AND RISK-BEARING PAYMENT MODELS DRIVE INVESTMENT 108 10.4 RISK STRATIFICATION & PREDICTIVE ANALYTICS 109 10.4.1 PREDICTIVE AI MODELS ENABLE EARLIER INTERVENTION AND PRECISION RISK MANAGEMENT AT SCALE 109 10.5 PATIENT ENGAGEMENT 110 10.5.1 DIGITAL PATIENT ACTIVATION PROGRAMS CLOSE CARE GAPS AND IMPROVE CHRONIC DISEASE OUTCOMES 110 10.6 PHYSICIAN ENGAGEMENT 111 10.6.1 CLINICAL DECISION SUPPORT AND QUALITY DASHBOARDS EMBEDDING PHM INTO DAILY PHYSICIAN WORKFLOWS 111 10.7 QUALITY & VALUE-BASED CARE MANAGEMENT 112 10.7.1 RECORD ACO SAVINGS AND EXPANDED VBC INCENTIVES ACCELERATE QUALITY MANAGEMENT PLATFORM ADOPTION 112 10.8 INTEROPERABILITY & DATA INTEGRATION 113 10.8.1 TEFCA EXPANSION AND FHIR STANDARDS STRENGTHENING INFRASTRUCTURE FOR PHM DATA EXCHANGE 113 10.9 OTHER FUNCTIONALITIES 114 10.9.1 PUBLIC HEALTH SURVEILLANCE MODERNIZATION AND SDOH INTEGRATION EXPAND MARKET BOUNDARIES 114 11 POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE 116 11.1 INTRODUCTION 117 11.2 CLOUD-BASED 117 11.2.1 INTEROPERABILITY MANDATES AND VBC SCALABILITY DEMANDS CEMENT CLOUD AS DOMINANT DELIVERY MODEL 117 11.3 ON-PREMISES 118 11.3.1 DATA SOVEREIGNTY, LEGACY INTEGRATION, AND REGULATORY COMPLIANCE SUSTAIN ON-PREMISES DEPLOYMENT 118 11.4 HYBRID 119 11.4.1 CLINICAL DATA CONTROL AND ANALYTICS SCALABILITY BALANCED THROUGH INTEGRATED HYBRID ARCHITECTURES 119 12 POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE 121 12.1 INTRODUCTION 122 12.2 LARGE ENTERPRISES 122 12.2.1 ENTERPRISE-WIDE DIGITAL TRANSFORMATION AND VALUE-BASED CARE INITIATIVES DRIVE MARKET LEADERSHIP 122 12.3 MEDIUM ENTERPRISES 123 12.3.1 INCREASING PARTICIPATION IN VALUE-BASED CARE DRIVES DEMAND FOR SCALABLE PHM SOLUTIONS 123 12.4 SMALL ENTERPRISES 124 12.4.1 SUBSCRIPTION-BASED DEPLOYMENT MODELS IMPROVE PHM ACCESSIBILITY AND MARKET PENETRATION 124 13 POPULATION HEALTH MANAGEMENT MARKET, BY END USER 126 13.1 INTRODUCTION 127 13.2 HEALTHCARE PROVIDERS 127 13.2.1 HOSPITALS & HEALTH SYSTEMS 128 13.2.1.1 Hospital digital transformation programs accelerate enterprise PHM platform deployment 128 13.2.2 PHYSICIAN PRACTICES & CLINICS 130 13.2.2.1 Independent practice value-based contracting creating scaled demand 130 13.2.3 OTHER HEALTHCARE PROVIDERS 131 13.2.3.1 Post-acute, behavioral health, and FQHC providers expand PHM market reach 131 13.3 HEALTHCARE PAYERS 131 13.3.1 RISK-BASED CONTRACTING EXPANSION AND CHRONIC DISEASE COST BURDEN DRIVE SEGMENT 131 13.3.2 PRIVATE PAYERS 133 13.3.2.1 Commercial VBC contracts and rising employer premiums accelerate adoption 133 13.3.3 PUBLIC PAYERS 134 13.3.3.1 CMS ACO expansion and Medicaid managed care growth reshaping public payer infrastructure 134 13.4 GOVERNMENT & PUBLIC HEALTH AGENCIES 135 13.4.1 PUBLIC HEALTH DATA MODERNIZATION AND GLOBAL DIGITAL HEALTH PROGRAMS BOOST GROWTH 135 13.5 EMPLOYERS 136 13.5.1 ESCALATING HEALTH BENEFIT COSTS AND CHRONIC DISEASE BURDEN COMPELLING EMPLOYER PHM PROGRAM INVESTMENT 136 13.6 LIFE SCIENCES 137 13.6.1 REAL-WORLD EVIDENCE GENERATION AND PATIENT RECRUITMENT DRIVE PHM PLATFORM ADOPTION 137 14 POPULATION HEALTH MANAGEMENT MARKET, BY REGION 138 14.1 INTRODUCTION 139 14.2 NORTH AMERICA 139 14.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 143 14.2.2 US 144 14.2.2.1 Value-based care and digital health transformation drive population health management adoption 144 14.2.3 CANADA 147 14.2.3.1 Digital health modernization & interoperability accelerate market growth 147 14.3 EUROPE 151 14.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 155 14.3.2 GERMANY 155 14.3.2.1 Health data utilization and digital care reforms advance population health management 155 14.3.3 FRANCE 159 14.3.3.1 National health data ecosystem and preventive healthcare accelerates market growth 159 14.3.4 UK 162 14.3.4.1 Integrated care systems and population health analytics transforming healthcare delivery 162 14.3.5 ITALY 166 14.3.5.1 Community healthcare transformation and digital care continuity strengthen market growth 166 14.3.6 SPAIN 169 14.3.6.1 Regional integrated care networks and chronic disease management drives market expansion 169 14.3.7 REST OF EUROPE 173 14.4 ASIA PACIFIC 176 14.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 180 14.4.2 CHINA 181 14.4.2.1 Healthy China 2030 and AI-driven healthcare transformation accelerate market growth 181 14.4.3 JAPAN 184 14.4.3.1 Healthy aging and community-based integrated care drive healthcare transformation 184 14.4.4 INDIA 188 14.4.4.1 Ayushman Bharat and digital public health infrastructure drive integrated care delivery 188 14.4.5 AUSTRALIA 191 14.4.5.1 Primary healthcare networks and digital health initiatives drive preventive care 191 14.4.6 SOUTH KOREA 195 14.4.6.1 AI-enabled healthcare and digital health innovation drive personalized care 195 14.4.7 REST OF ASIA PACIFIC 198 14.5 LATIN AMERICA 201 14.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 205 14.5.2 BRAZIL 205 14.5.2.1 National Health Data Network (RNDS) and digital health transformation strengthen market 205 14.5.3 MEXICO 209 14.5.3.1 Electronic health record standardization and healthcare digitalization support market growth 209 14.5.4 REST OF LATIN AMERICA 212 14.6 MIDDLE EAST & AFRICA 215 14.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 216 14.6.2 GCC COUNTRIES 219 14.6.2.1 Saudi Arabia 223 14.6.2.1.1 Vision 2030 and AI-enabled healthcare transformation advancing population health management 223 14.6.2.2 UAE 226 14.6.2.2.1 AI-driven healthcare and national health data platforms accelerating population health management 226 14.6.2.3 Other GCC countries 230 14.6.2.3.1 National healthcare diversification creating opportunities for population health management 230 14.6.3 SOUTH AFRICA 233 14.6.3.1 National health insurance and primary healthcare reforms drive market 233 14.6.4 REST OF MIDDLE EAST & AFRICA 236 15 COMPETITIVE LANDSCAPE 240 15.1 INTRODUCTION 240 15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 240 15.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN POPULATION HEALTH MANAGEMENT MARKET 241 15.3 REVENUE SHARE ANALYSIS, 2021–2025 242 15.4 MARKET SHARE ANALYSIS, 2025 243 15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 245 15.5.1 STARS 246 15.5.2 PERVASIVE PLAYERS 246 15.5.3 EMERGING LEADERS 246 15.5.4 PARTICIPANTS 246 15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 248 15.5.5.1 Company footprint 248 15.5.5.2 Region footprint 248 15.5.5.3 Component footprint 249 15.5.5.4 Functionality footprint 250 15.5.5.5 Delivery mode footprint 251 15.5.5.6 End user footprint 251 15.6 COMPANY EVALUATION MATRIX: STARTUPS /SMES, 2025 252 15.6.1 PROGRESSIVE COMPANIES 252 15.6.2 DYNAMIC COMPANIES 252 15.6.3 STARTING BLOCKS 252 15.6.4 RESPONSIVE COMPANIES 253 15.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 254 15.7 COMPANY VALUATION & FINANCIAL METRICS 257 15.7.1 FINANCIAL METRICS 257 15.7.2 COMPANY VALUATION 257 15.8 BRAND/SOFTWARE COMPARISON ANALYSIS 258 15.9 COMPETITIVE SCENARIO 258 15.9.1 PRODUCT LAUNCHES & DEVELOPMENTS 258 15.9.2 DEALS 259 15.9.3 OTHER DEVELOPMENTS 260 16 COMPANY PROFILES 261 16.1 KEY PLAYERS 261 16.1.1 ORACLE 261 16.1.1.1 Business overview 261 16.1.1.2 Products offered 262 16.1.1.3 Recent developments 263 16.1.1.3.1 Product launches & approvals 263 16.1.1.3.2 Deals 263 16.1.1.3.3 Other developments 264 16.1.1.4 MnM view 264 16.1.1.4.1 Right to win 264 16.1.1.4.2 Strategic choices 264 16.1.1.4.3 Weaknesses & competitive threats 264 16.1.2 OPTUM, INC. 265 16.1.2.1 Business overview 265 16.1.2.2 Products offered 266 16.1.2.3 Recent developments 267 16.1.2.3.1 Deals 267 16.1.2.4 MnM view 267 16.1.2.4.1 Right to win 267 16.1.2.4.2 Strategic choices 267 16.1.2.4.3 Weaknesses & competitive threats 267 16.1.3 KONINKLIJKE PHILIPS N.V. 268 16.1.3.1 Business overview 268 16.1.3.2 Products offered 269 16.1.3.3 Recent developments 270 16.1.3.3.1 Product launches & approvals 270 16.1.3.3.2 Deals 271 16.1.3.4 MnM view 271 16.1.3.4.1 Right to win 271 16.1.3.4.2 Strategic choices 271 16.1.3.4.3 Weaknesses & competitive threats 272 16.1.4 EPIC SYSTEMS CORPORATION 273 16.1.4.1 Business overview 273 16.1.4.2 Products offered 273 16.1.4.3 Recent developments 274 16.1.4.3.1 Product launches & approvals 274 16.1.4.3.2 Deals 274 16.1.4.4 MnM view 275 16.1.4.4.1 Right to win 275 16.1.4.4.2 Strategic choices 275 16.1.4.4.3 Weaknesses & competitive threats 275 16.1.5 MERATIVE 276 16.1.5.1 Business overview 276 16.1.5.2 Products offered 277 16.1.5.3 Recent developments 277 16.1.5.3.1 Deals 277 16.1.5.3.2 Expansions 278 16.1.5.4 MnM view 278 16.1.5.4.1 Right to win 278 16.1.5.4.2 Strategic choices 278 16.1.5.4.3 Weaknesses & competitive threats 278 16.1.6 VERADIGM LLC 279 16.1.6.1 Business overview 279 16.1.6.2 Products offered 280 16.1.6.3 Recent developments 281 16.1.6.3.1 Deals 281 16.1.6.3.2 Other developments 281 16.1.7 I2I POPULATION HEALTH 282 16.1.7.1 Business overview 282 16.1.7.2 Products offered 283 16.1.7.3 Recent developments 283 16.1.7.3.1 Deals 283 16.1.8 HEALTH CATALYST 284 16.1.8.1 Business overview 284 16.1.8.2 Products offered 285 16.1.8.3 Recent developments 286 16.1.8.3.1 Product launches & approvals 286 16.1.8.3.2 Deals 286 16.1.9 CEDAR GATE TECHNOLOGIES 287 16.1.9.1 Business overview 287 16.1.9.2 Products offered 287 16.1.9.3 Recent developments 288 16.1.9.3.1 Product launches & approvals 288 16.1.10 ECLINICALWORKS 289 16.1.10.1 Business overview 289 16.1.10.2 Products offered 289 16.1.10.3 Recent developments 290 16.1.10.3.1 Product launches & approvals 290 16.1.11 ELLIGINT HEALTH 291 16.1.11.1 Business overview 291 16.1.11.2 Products offered 292 16.1.12 MEDECISION 293 16.1.12.1 Business overview 293 16.1.12.2 Products offered 293 16.1.12.3 Recent developments 294 16.1.12.3.1 Product launches & approvals 294 16.1.12.3.2 Deals 295 16.1.13 ARCADIA 296 16.1.13.1 Business overview 296 16.1.13.2 Products offered 296 16.1.13.3 Recent developments 297 16.1.13.3.1 Deals 297 16.1.14 ATHENAHEALTH 298 16.1.14.1 Business overview 298 16.1.14.2 Products offered 298 16.1.14.3 Recent developments 299 16.1.14.3.1 Deals 299 16.1.15 COTIVITI, INC. 300 16.1.15.1 Business overview 300 16.1.15.2 Products offered 300 16.1.15.3 Recent developments 301 16.1.15.3.1 Deals 301 16.1.15.3.2 Other developments 301 16.1.16 NXGN MANAGEMENT, LLC. (NEXTGEN HEALTHCARE) 302 16.1.16.1 Business overview 302 16.1.16.2 Products offered 303 16.2 OTHER PLAYERS 304 16.2.1 MEDEANALYTICS, INC. 304 16.2.2 CONIFER HEALTH SOLUTIONS 305 16.2.3 LIGHTBEAM HEALTH SOLUTIONS 306 16.2.4 INNOVACCER 307 16.2.5 LUMERIS 308 16.2.6 ZEOMEGA 309 16.2.7 MILLIMAN MEDINSIGHT (A MILLIMAN COMPANY) 310 16.2.8 PERSIVIA 311 16.2.9 COLOR HEALTH, INC. 312 17 RESEARCH METHODOLOGY 313 17.1 RESEARCH APPROACH 313 17.1.1 SECONDARY RESEARCH 313 17.1.1.1 Key data from secondary sources 314 17.1.2 PRIMARY RESEARCH 315 17.1.2.1 Primary sources 315 17.1.2.2 Key data from primary sources 316 17.1.2.3 Breakdown of primaries 316 17.1.2.4 Insights from primary experts 317 17.2 RESEARCH METHODOLOGY 317 17.3 MARKET SIZE ESTIMATION 318 17.4 MARKET BREAKDOWN DATA TRIANGULATION 323 17.5 MARKET SHARE ESTIMATION 324 17.6 STUDY ASSUMPTIONS 324 17.7 RESEARCH LIMITATIONS 324 17.7.1 METHODOLOGY-RELATED LIMITATIONS 324 17.8 RISK ASSESSMENT 325 18 APPENDIX 326 18.1 DISCUSSION GUIDE 326 18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 331 18.3 CUSTOMIZATION OPTIONS 333 18.4 RELATED REPORTS 333 18.5 AUTHOR DETAILS 334

圖表清單 List of Tables & Figures

TABLE 1 EXCHANGE RATES USED FOR CONVERSION TO USD 34 TABLE 2 US: BIGGEST HEALTHCARE DATA BREACHES OF 2025 49 TABLE 3 HEALTHCARE EDI MARKET: PORTER’S FIVE FORCES ANALYSIS 57 TABLE 4 POPULATION HEALTH MANAGEMENT MARKET: ROLE IN ECOSYSTEM 62 TABLE 5 INDICATIVE PRICE FOR POPULATION HEALTH MANAGEMENT SOLUTIONS, BY COMPONENT (2025) 64 TABLE 6 INDICATIVE PRICE FOR POPULATION HEALTH MANAGEMENT SOLUTIONS, BY REGION (2025) 65 TABLE 7 POPULATION HEALTH MANAGEMENT MARKET: KEY CONFERENCES & EVENTS, 2026–2027 65 TABLE 8 CASE 1: ACCELERATED VALUE-BASED CARE DELIVERY WITH AI-DRIVEN POPULATION HEALTH MANAGEMENT 68 TABLE 9 CASE 2: IMPROVED COMMUNITY HEALTH THROUGH DATA-DRIVEN POPULATION HEALTH ANALYTICS 68 TABLE 10 CASE 3: REDUCED EMERGENCY DEPARTMENT VISITS THROUGH AI-ENABLED POPULATION HEALTH MANAGEMENT 69 TABLE 11 US ADJUSTED RECIPROCAL TARIFF RATES 70 TABLE 12 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR POPULATION HEALTH MANAGEMENT MARKET 78 TABLE 13 POPULATION HEALTH MANAGEMENT MARKET: KEY PATENTS/PATENT APPLICATIONS 79 TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88 TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88 TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89 TABLE 17 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90 TABLE 18 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90 TABLE 19 REGULATORY SCENARIO OF NORTH AMERICA 91 TABLE 20 REGULATORY SCENARIO OF EUROPE 92 TABLE 21 REGULATORY SCENARIO OF ASIA PACIFIC 93 TABLE 22 REGULATORY SCENARIO OF LATIN AMERICA 94 TABLE 23 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA 94 TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS (%) 98 TABLE 25 KEY BUYING CRITERIA FOR TOP THREE END USERS 99 TABLE 26 UNMET NEEDS IN POPULATION HEALTH MANAGEMENT MARKET 100 TABLE 27 END-USER EXPECTATIONS IN POPULATION HEALTH MANAGEMENT MARKET 101 TABLE 28 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 103 TABLE 29 POPULATION HEALTH MANAGEMENT SOFTWARE MARKET, BY REGION, 2024–2031 (USD MILLION) 104 TABLE 30 POPULATION HEALTH MANAGEMENT SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 105 TABLE 31 POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 107 TABLE 32 POPULATION HEALTH ANALYTICS: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 108 TABLE 33 CARE MANAGEMENT & CARE COORDINATION: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 109 TABLE 34 RISK STRATIFICATION & PREDICTIVE ANALYTICS: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 110 TABLE 35 PATIENT ENGAGEMENT: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 111 TABLE 36 PHYSICIAN ENGAGEMENT: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 112 TABLE 37 QUALITY & VALUE-BASED CARE MANAGEMENT: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 113 TABLE 38 INTEROPERABILITY & DATA INTEGRATION: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 114 TABLE 39 OTHER FUNCTIONALITIES: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 115 TABLE 40 POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 117 TABLE 41 CLOUD-BASED: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 118 TABLE 42 ON-PREMISES: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 119 TABLE 43 HYBRID: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 120 TABLE 44 POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 122 TABLE 45 POPULATION HEALTH MANAGEMENT MARKET FOR LARGE ENTERPRISES, BY REGION, 2024–2031 (USD MILLION) 123 TABLE 46 POPULATION HEALTH MANAGEMENT MARKET FOR MEDIUM ENTERPRISES, BY REGION, 2024–2031 (USD MILLION) 124 TABLE 47 POPULATION HEALTH MANAGEMENT MARKET FOR SMALL ENTERPRISES, BY REGION, 2024–2031 (USD MILLION) 125 TABLE 48 POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 127 TABLE 49 POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 128 TABLE 50 HEALTHCARE PROVIDERS: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 128 TABLE 51 POPULATION HEALTH MANAGEMENT MARKET FOR HOSPITALS AND HEALTH SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 129 TABLE 52 POPULATION HEALTH MANAGEMENT MARKET FOR PHYSICIAN PRACTICES & CLINICS, BY REGION, 2024–2031 (USD MILLION) 130 TABLE 53 POPULATION HEALTH MANAGEMENT MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2024–2031 (USD MILLION) 131 TABLE 54 POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 132 TABLE 55 HEALTHCARE PAYERS: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 132 TABLE 56 POPULATION HEALTH MANAGEMENT MARKET FOR PRIVATE PAYERS, BY REGION, 2024–2031 (USD MILLION) 133 TABLE 57 POPULATION HEALTH MANAGEMENT MARKET FOR PUBLIC PAYERS, BY REGION, 2024–2031 (USD MILLION) 134 TABLE 58 GOVERNMENT & PUBLIC HEALTH AGENCIES: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 135 TABLE 59 EMPLOYERS: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 136 TABLE 60 LIFE SCIENCES: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 137 TABLE 61 POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 139 TABLE 62 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 140 TABLE 63 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 141 TABLE 64 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 141 TABLE 65 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 142 TABLE 66 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 142 TABLE 67 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 142 TABLE 68 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 143 TABLE 69 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 143 TABLE 70 US: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 145 TABLE 71 US: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 145 TABLE 72 US: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 146 TABLE 73 US: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 146 TABLE 74 US: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 146 TABLE 75 US: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 147 TABLE 76 US: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 147 TABLE 77 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 148 TABLE 78 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 149 TABLE 79 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 149 TABLE 80 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 150 TABLE 81 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 150 TABLE 82 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 150 TABLE 83 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 151 TABLE 84 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 152 TABLE 85 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 152 TABLE 86 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 153 TABLE 87 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 153 TABLE 88 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 154 TABLE 89 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 154 TABLE 90 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 154 TABLE 91 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 155 TABLE 92 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 156 TABLE 93 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 157 TABLE 94 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 157 TABLE 95 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 158 TABLE 96 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 158 TABLE 97 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 158 TABLE 98 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 159 TABLE 99 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 160 TABLE 100 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 160 TABLE 101 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 161 TABLE 102 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 161 TABLE 103 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 161 TABLE 104 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 162 TABLE 105 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 162 TABLE 106 UK: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 163 TABLE 107 UK: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 164 TABLE 108 UK: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 164 TABLE 109 UK: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 165 TABLE 110 UK: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 165 TABLE 111 UK: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 165 TABLE 112 UK: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 166 TABLE 113 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 167 TABLE 114 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 167 TABLE 115 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 168 TABLE 116 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 168 TABLE 117 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 168 TABLE 118 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 169 TABLE 119 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 169 TABLE 120 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 170 TABLE 121 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 171 TABLE 122 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 171 TABLE 123 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 172 TABLE 124 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 172 TABLE 125 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 172 TABLE 126 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 173 TABLE 127 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 174 TABLE 128 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 174 TABLE 129 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 175 TABLE 130 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 175 TABLE 131 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 175 TABLE 132 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 176 TABLE 133 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 176 TABLE 134 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 177 TABLE 135 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 178 TABLE 136 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 178 TABLE 137 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 179 TABLE 138 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 179 TABLE 139 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 179 TABLE 140 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 180 TABLE 141 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 180 TABLE 142 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 182 TABLE 143 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 182 TABLE 144 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 183 TABLE 145 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 183 TABLE 146 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 183 TABLE 147 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 184 TABLE 148 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 184 TABLE 149 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 185 TABLE 150 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 186 TABLE 151 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 186 TABLE 152 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 187 TABLE 153 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 187 TABLE 154 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 187 TABLE 155 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 188 TABLE 156 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 189 TABLE 157 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 189 TABLE 158 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 190 TABLE 159 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 190 TABLE 160 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 190 TABLE 161 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 191 TABLE 162 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 191 TABLE 163 AUSTRALIA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 192 TABLE 164 AUSTRALIA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 193 TABLE 165 AUSTRALIA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 193 TABLE 166 AUSTRALIA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 194 TABLE 167 AUSTRALIA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 194 TABLE 168 AUSTRALIA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 194 TABLE 169 AUSTRALIA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 195 TABLE 170 SOUTH KOREA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 196 TABLE 171 SOUTH KOREA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 196 TABLE 172 SOUTH KOREA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 197 TABLE 173 SOUTH KOREA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 197 TABLE 174 SOUTH KOREA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 197 TABLE 175 SOUTH KOREA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 198 TABLE 176 SOUTH KOREA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 198 TABLE 177 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 199 TABLE 178 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 199 TABLE 179 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 200 TABLE 180 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 200 TABLE 181 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 200 TABLE 182 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 201 TABLE 183 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 201 TABLE 184 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 202 TABLE 185 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 202 TABLE 186 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 203 TABLE 187 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 203 TABLE 188 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 204 TABLE 189 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 204 TABLE 190 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 204 TABLE 191 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 205 TABLE 192 BRAZIL: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 206 TABLE 193 BRAZIL: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 207 TABLE 194 BRAZIL: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 207 TABLE 195 BRAZIL: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 208 TABLE 196 BRAZIL: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 208 TABLE 197 BRAZIL: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 208 TABLE 198 BRAZIL: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 209 TABLE 199 MEXICO: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 210 TABLE 200 MEXICO: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 210 TABLE 201 MEXICO: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 211 TABLE 202 MEXICO: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 211 TABLE 203 MEXICO: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 211 TABLE 204 MEXICO: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 212 TABLE 205 MEXICO: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 212 TABLE 206 REST OF LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 213 TABLE 207 REST OF LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 213 TABLE 208 REST OF LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 214 TABLE 209 REST OF LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 214 TABLE 210 REST OF LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 214 TABLE 211 REST OF LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 215 TABLE 212 REST OF LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 215 TABLE 213 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 216 TABLE 214 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 217 TABLE 215 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 217 TABLE 216 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 218 TABLE 217 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 218 TABLE 218 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 218 TABLE 219 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 219 TABLE 220 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 219 TABLE 221 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 220 TABLE 222 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 220 TABLE 223 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 221 TABLE 224 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 221 TABLE 225 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 222 TABLE 226 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 222 TABLE 227 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 222 TABLE 228 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 223 TABLE 229 SAUDI ARABIA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 224 TABLE 230 SAUDI ARABIA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 224 TABLE 231 SAUDI ARABIA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 225 TABLE 232 SAUDI ARABIA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 225 TABLE 233 SAUDI ARABIA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 225 TABLE 234 SAUDI ARABIA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 226 TABLE 235 SAUDI ARABIA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 226 TABLE 236 UAE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 227 TABLE 237 UAE: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 228 TABLE 238 UAE: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 228 TABLE 239 UAE: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 229 TABLE 240 UAE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 229 TABLE 241 UAE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 229 TABLE 242 UAE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 230 TABLE 243 OTHER GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 231 TABLE 244 OTHER GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 231 TABLE 245 OTHER GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 232 TABLE 246 OTHER GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 232 TABLE 247 OTHER GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 232 TABLE 248 OTHER GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 233 TABLE 249 OTHER GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 233 TABLE 250 SOUTH AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 234 TABLE 251 SOUTH AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 234 TABLE 252 SOUTH AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 235 TABLE 253 SOUTH AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 235 TABLE 254 SOUTH AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 235 TABLE 255 SOUTH AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 236 TABLE 256 SOUTH AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 236 TABLE 257 REST OF MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 237 TABLE 258 REST OF MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 237 TABLE 259 REST OF MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 238 TABLE 260 REST OF MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 238 TABLE 261 REST OF MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 238 TABLE 262 REST OF MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 239 TABLE 263 REST OF MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 239 TABLE 264 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES 241 TABLE 265 POPULATION HEALTH MANAGEMENT MARKET: DEGREE OF COMPETITION 244 TABLE 266 POPULATION HEALTH MANAGEMENT MARKET: REGION FOOTPRINT 248 TABLE 267 POPULATION HEALTH MANAGEMENT MARKET: COMPONENT FOOTPRINT 249 TABLE 268 POPULATION HEALTH MANAGEMENT MARKET: FUNCTIONALITY ANALYSIS 250 TABLE 269 POPULATION HEALTH MANAGEMENT MARKET: DELIVERY MODE FOOTPRINT 251 TABLE 270 END USER FOOTPRINT ANALYSIS 251 TABLE 271 POPULATION HEALTH MANAGEMENT MARKET: DETAILED LIST OF KEY START-UPS/SMES 254 TABLE 272 KEY EMERGING PLAYERS/STARTUPS: REGION FOOTPRINT 254 TABLE 273 KEY EMERGING PLAYERS/STARTUPS: COMPONENT FOOTPRINT 255 TABLE 274 KEY EMERGING PLAYERS/STARTUPS: FUNCTIONALITY FOOTPRINT 255 TABLE 275 KEY EMERGING PLAYERS/STARTUPS: DELIVERY MODE FOOTPRINT 256 TABLE 276 KEY EMERGING PLAYERS/STARTUPS: END USER FOOTPRINT 256 TABLE 277 POPULATION HEALTH MANAGEMENT MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JULY 2026 258 TABLE 278 POPULATION HEALTH MANAGEMENT MARKET: DEALS, JANUARY 2023–JULY 2026 259 TABLE 279 POPULATION HEALTH MANAGEMENT MARKET: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 260 TABLE 280 ORACLE: COMPANY OVERVIEW 261 TABLE 281 ORACLE: PRODUCTS OFFERED 262 TABLE 282 ORACLE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JULY 2026 263 TABLE 283 ORACLE: DEALS, JANUARY 2023–JULY 2026 263 TABLE 284 ORACLE: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 264 TABLE 285 OPTUM INC.: COMPANY OVERVIEW 265 TABLE 286 OPTUM, INC.: PRODUCTS OFFERED 266 TABLE 287 OPTUM, INC.: DEALS, JANUARY 2023–JULY 2026 267 TABLE 288 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 268 TABLE 289 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 269 TABLE 290 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JULY 2026 270 TABLE 291 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2023–JULY 2026 271 TABLE 292 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW 273 TABLE 293 EPIC SYSTEMS CORPORATION: PRODUCTS OFFERED 273 TABLE 294 EPIC SYSTEMS CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JULY 2026 274 TABLE 295 EPIC SYSTEMS CORPORATION: DEALS, JANUARY 2023–JULY 2026 274 TABLE 296 MERATIVE: COMPANY OVERVIEW 276 TABLE 297 MERATIVE: PRODUCTS OFFERED 277 TABLE 298 MERATIVE: DEALS, JANUARY 2023–JULY2026 277 TABLE 299 MERATIVE: EXPANSIONS, JANUARY 2023–JULY 2026 278 TABLE 300 VERADIGM LLC: COMPANY OVERVIEW 279 TABLE 301 VERADIGM LLC: PRODUCTS OFFERED 280 TABLE 302 VERADIGM LLC: DEALS, JANUARY 2023–JULY 2026 281 TABLE 303 VERADIGM LLC: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 281 TABLE 304 I2I POPULATION HEALTH: COMPANY OVERVIEW 282 TABLE 305 I2I POPULATION HEALTH: PRODUCTS OFFERED 283 TABLE 306 I2I POPULATION HEALTH: DEALS, JANUARY 2023–JULY 2026 283 TABLE 307 HEALTH CATALYST: COMPANY OVERVIEW 284 TABLE 308 HEALTH CATALYST: PRODUCTS OFFERED 285 TABLE 309 HEALTH CATALYST: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JULY 2026 286 TABLE 310 HEALTH CATALYST: DEALS, JANUARY 2023–JULY 2026 286 TABLE 311 CEDAR GATE TECHNOLOGIES: COMPANY OVERVIEW 287 TABLE 312 CEDAR GATE TECHNOLOGIES: PRODUCTS OFFERED 287 TABLE 313 CEDAR GATE TECHNOLOGIES: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JULY 2026 288 TABLE 314 ECLINICALWORKS: COMPANY OVERVIEW 289 TABLE 315 ECLINICALWORKS: PRODUCTS OFFERED 289 TABLE 316 ECLINICALWORKS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JULY 2026 290 TABLE 317 ELLIGINT HEALTH: COMPANY OVERVIEW 291 TABLE 318 ELLIGINT HEALTH: PRODUCTS OFFERED 292 TABLE 319 MEDECISION: COMPANY OVERVIEW 293 TABLE 320 MEDECISION: PRODUCTS OFFERED 293 TABLE 321 MEDECISION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JULY 2026 294 TABLE 322 MEDECISION: DEALS, JANUARY 2023–JULY 2026 295 TABLE 323 ARCADIA: COMPANY OVERVIEW 296 TABLE 324 ARCADIA: PRODUCTS OFFERED 296 TABLE 325 ARCADIA: DEALS, JANUARY 2023–JULY 2026 297 TABLE 326 ATHENAHEALTH: COMPANY OVERVIEW 298 TABLE 327 ATHENAHEALTH: PRODUCTS OFFERED 298 TABLE 328 ATHENAHEALTH: DEALS, JANUARY 2023–JULY 2026 299 TABLE 329 COTIVITI, INC.: COMPANY OVERVIEW 300 TABLE 330 COTIVITI, INC.: PRODUCTS OFFERED 300 TABLE 331 COTIVITI, INC.: DEALS, JANUARY 2023–MAY 2026 301 TABLE 332 COTIVITI, INC.: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 301 TABLE 333 NXGN MANAGEMENT, LLC.: COMPANY OVERVIEW 302 TABLE 334 NXGN MANAGEMENT, LLC.: PRODUCTS OFFERED 303 TABLE 335 RISK ASSESSMENT: POPULATION HEALTH MANAGEMENT MARKET 325 FIGURE 1 POPULATION HEALTH MANAGEMENT MARKET SEGMENTATION 32 FIGURE 2 MARKET SCENARIO 38 FIGURE 3 GLOBAL POPULATION HEALTH MANAGEMENT MARKET, 2024–2031 38 FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN POPULATION HEALTH MANAGEMENT MARKET, 2023–2026 39 FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF POPULATION HEALTH MANAGEMENT MARKET 40 FIGURE 6 HIGH-GROWTH SEGMENTS IN POPULATION HEALTH MANAGEMENT MARKET, 2026–2031 41 FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN POPULATION HEALTH MANAGEMENT MARKET DURING FORECAST PERIOD 42 FIGURE 8 VALUE-BASED CARE AND HEALTHCARE DIGITALIZATION ACCELERATING GROWTH IN POPULATION HEALTH MANAGEMENT MARKET 43 FIGURE 9 SERVICES ACCOUNTED FOR LARGEST MARKET SHARE IN NORTH AMERICA IN 2025 44 FIGURE 10 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 44 FIGURE 11 POPULATION HEALTH MANAGEMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 45 FIGURE 12 HEALTHCARE DATA BREACH ATTACK VECTORS, 2025 49 FIGURE 13 POPULATION HEALTH MANAGEMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 56 FIGURE 14 POPULATION HEALTH MANAGEMENT MARKET: VALUE CHAIN ANALYSIS 60 FIGURE 15 POPULATION HEALTH MANAGEMENT MARKET: ECOSYSTEM ANALYSIS 62 FIGURE 16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 67 FIGURE 18 PATENT PUBLICATION TRENDS IN POPULATION HEALTH MANAGEMENT MARKET, 2015–2026 77 FIGURE 19 JURISDICTION AND TOP APPLICANT ANALYSIS FOR POPULATION HEALTH MANAGEMENT MARKET 78 FIGURE 20 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR POPULATION HEALTH MANAGEMENT MARKET (JANUARY 2015 TO JULY 2026) 79 FIGURE 21 MARKET POTENTIAL OF AI/GEN AI ON POPULATION HEALTH MANAGEMENT SOLUTIONS ACROSS INDUSTRIES 82 FIGURE 22 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 84 FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 97 FIGURE 24 KEY BUYING CRITERIA FOR TOP THREE END USERS 98 FIGURE 25 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET SNAPSHOT 140 FIGURE 26 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET SNAPSHOT 177 FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS IN POPULATION HEALTH MANAGEMENT MARKET, 2021–2025 (USD BILLION) 243 FIGURE 28 POPULATION HEALTH MANAGEMENT: MARKET SHARE ANALYSIS, 2025 244 FIGURE 29 POPULATION HEALTH MANAGEMENT MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 247 FIGURE 30 POPULATION HEALTH MANAGEMENT MARKET: COMPANY FOOTPRINT 248 FIGURE 31 POPULATION HEALTH MANAGEMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 253 FIGURE 32 EV/EBITDA OF KEY VENDORS 257 FIGURE 33 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF POPULATION HEALTH MANAGEMENT SOLUTION VENDORS 257 FIGURE 34 POPULATION HEALTH MANAGEMENT MARKET: BRAND/PRODUCT COMPARISON ANALYSIS 258 FIGURE 35 ORACLE: COMPANY SNAPSHOT (2025) 262 FIGURE 36 OPTUM, INC.: COMPANY SNAPSHOT (2025) 266 FIGURE 37 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025) 269 FIGURE 38 VERADIGM LLC: COMPANY SNAPSHOT (2025) 280 FIGURE 39 HEALTH CATALYST: COMPANY SNAPSHOT (2025) 285 FIGURE 40 RESEARCH DESIGN 313 FIGURE 41 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 316 FIGURE 42 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 318 FIGURE 43 BOTTOM-UP APPROACH 319 FIGURE 44 TOP-DOWN APPROACH 319 FIGURE 45 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF POPULATION HEALTH MANAGEMENT SOLUTIONS INDUSTRY 320 FIGURE 46 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 321 FIGURE 47 DATA TRIANGULATION METHODOLOGY 323

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們